Back

prof. dr. J.P. (Jelle) Ruurda

Full Professor

  • Department of Surgical Oncology

Research Output (251)

The CARDIA-trial protocol:a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II

Leers Jessica M, Knepper Laura, van der Veen Arjen, Schröder Wolfgang, Fuchs Hans, Schiller Petra, Hellmich Martin, Zettelmeyer Ulrike, Brosens Lodewijk A A, Quaas Alexander, Ruurda Jelle P, van Hillegersberg Richard, Bruns Christiane J 20 aug 2020, In: BMC Cancer. 20 , p. 781

The additive value of restaging-CT during neoadjuvant chemotherapy for gastric cancer

Gertsen E. C., de Jongh C., Brenkman H. J.F., Mertens A. C., Broeders I. A.M.J., Los M., Boerma D., ten Bokkel Huinink D., van Leeuwen L., Wessels F. J., van Hillegersberg R., Ruurda J. P. jul 2020, In: European Journal of Surgical Oncology. 46 , p. 1247-1253 7 p.

Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer:a prospective study with weekly MRI

Defize Ingmar L, Boekhoff Mick R, Borggreve Alicia S, van Lier Astrid L H M W, Takahashi Noriyoshi, Haj Mohammad Nadia, Ruurda Jelle P, van Hillegersberg Richard, Mook Stella, Meijer Gert J jul 2020, In: Acta Oncologica. 59 , p. 753-759 7 p.

Metastatic incidence of (PET)CT positive lung hilar and retroperitoneal lymph nodes in esophageal cancer patients

Schurink B., Mazza E., Ruurda J. P., Roeling T. A.P., Bleys R. L.A.W., van Hillegersberg R. 1 jun 2020, In: Surgical Oncology. 33 , p. 170-176 7 p.

3-Dimensional target coverage assessment for MRI guided esophageal cancer radiotherapy

Boekhoff M. R., Defize I. L., Borggreve A. S., Takahashi N., van Lier A. L.H.M.W., Ruurda J. P., van Hillegersberg R., Lagendijk J. J.W., Mook S., Meijer G. J. 1 jun 2020, In: Radiotherapy and Oncology. 147 , p. 1-7 7 p.

Do esophageal cancer survivors work after esophagectomy and do health problems impact their work? A cross-sectional study

Kingma B. F., Rauwerdink P., Brenkman H. J.F., Ruurda J. P., van Hillegersberg R. 1 jun 2020, In: Journal of Cancer Survivorship. 14 , p. 253-260 8 p.

Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer

Borggreve Alicia S, Heethuis Sophie E, Boekhoff Mick R, Goense Lucas, van Rossum Peter S N, Brosens Lodewijk A A, van Lier Astrid L H M W, van Hillegersberg Richard, Lagendijk Jan J W, Mook Stella, Ruurda Jelle P, Meijer Gert J 1 apr 2020, In: European Radiology. 30 , p. 1896-1907 12 p.

Robot-assisted minimally invasive esophagectomy (RAMIE) compared to conventional minimally invasive esophagectomy (MIE) for esophageal cancer:a propensity-matched analysis

Tagkalos E, Goense L, Hoppe-Lotichius M, Ruurda J P, Babic B, Hadzijusufovic E, Kneist W, van der Sluis P C, Lang H, van Hillegersberg R, Grimminger P P 1 apr 2020, In: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 33 6 p.

Feasibility of extended chemoradiotherapy plus surgery for patients with cT4b esophageal carcinoma

Anderegg Martinus C J, Ruurda Jelle P, Gisbertz Suzanne S, Blom Rachel L G M, Sosef Meindert N, Wijnhoven Bas P L, Hulshof Maarten C C M, Bergman Jacques J G H M, van Laarhoven Hanneke W M, van Berge Henegouwen Mark I apr 2020, In: European Journal of Surgical Oncology. 46 , p. 626-631 6 p.

The potential and challenges of patient-derived organoids in guiding the multimodality treatment of upper gastrointestinal malignancies

Busslinger Georg A, Lissendorp Fianne, Franken Ingrid A, van Hillegersberg Richard, Ruurda Jelle P, Clevers Hans, de Maat Michiel F G apr 2020, In: Open Biology. 10 6 p.